Bausch Health
BHC
#4785
Rank
A$2.71 B
Marketcap
A$7.30
Share price
-1.95%
Change (1 day)
-29.18%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): A$1.48

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is A$1.41. In 2024 the company made an earnings per share (EPS) of A-$0.17 an increase over its 2023 EPS that were of A-$2.36.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$1.48-947.57%
2024A-$0.17-92.59%
2023A-$2.36160.89%
2022A-$0.90-76.64%
2021A-$3.8768.45%
2020A-$2.30-68.91%
2019A-$7.38-57.11%
2018A-$17.22-272.22%
2017A$10.00-199.29%
2016A-$10.07798.7%
2015A-$1.12-128.31%
2014A$3.96-204.62%
2013A-$3.78602.7%
2012A-$0.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
A-$0.35-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A-$1.38-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA